Elma Mujaković

Dr. Elma Mujaković

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2026 in Cureus
Verified
Journal Article
Open access
PDF file
MAMirha M. Agic
Mirha M. Agic
EIEnes Idrizovic
Enes Idrizovic
EMElma Mujaković
Elma Mujaković
ACAnis Cerovac
Anis Cerovac
ZMZlatan Mehmedovic
Zlatan Mehmedovic
MAMirha Agic
Mirha Agic
Background: The early postoperative period following colorectal cancer resection is characterized by metabolic stress, protein catabolism, and systemic inflammation. Although perioperative nutritional support is increasingly recognized as an important component of surgical care, its relationship with short-term changes in serum proteins and inflammatory markers has been less extensively investigated. Methods: This prospective, comparative study included 60 adults undergoing elective open colorectal cancer resection with primary anastomosis. The supplementation group included 30 patients who received 300 mL/day of an enteral nutritional formula for two days before and seven days after surgery, with postoperative supplementation initiated 24 hours after the procedure. Standard nutritional care without enteral supplementation was provided to the remaining 30 patients. Serum total protein, albumin, C-reactive protein (CRP), and fibrinogen were assessed preoperatively and on postoperative days (PODs) 3, 5, and 7. Early postoperative morbidity was evaluated within seven days. Results: Baseline total protein, erythrocyte count, and fibrinogen were higher in the supplementation group. From baseline to POD7, mean decreases in total protein (5.07 ± 4.43 vs 9.57 ± 2.65 g/L; t(58) = 4.77, p < 0.001) and albumin (5.20 ± 4.37 vs 9.37 ± 2.74 g/L; t(58) = 4.43, p < 0.001) were smaller in the supplementation group. Mean increases in CRP (18.02 ± 18.55 vs 36.59 ± 27.87 mg/L; t(58) = -3.04, p = 0.004) and fibrinogen (0.97 ± 0.85 vs 2.67 ± 0.60 g/L; t(58) = -8.95, p < 0.001) were also smaller. Early postoperative complications occurred in two of 30 patients in the supplementation group and five of 30 patients in the standard-care group. No in-hospital deaths occurred. Conclusion: Perioperative enteral supplementation was associated with smaller early postoperative decreases in serum total protein and albumin and smaller increases in CRP and fibrinogen following colorectal cancer resection. The clinical significance of these biochemical differences remains uncertain, and the comparison of early postoperative morbidity was inconclusive. Given the study design and baseline imbalances, the findings warrant confirmation in larger, adequately controlled studies.

13 December 2025
Verified
Journal Article
Closed access
EMElma Mujaković
Elma Mujaković
ATAnesa Terzić
Anesa Terzić
MBMinela Bećirović
Minela Bećirović
EBEmir Bećirović
Emir Bećirović
EZEsma Zejnilagić
Esma Zejnilagić
AMAlmedina Muhić
Almedina Muhić

4 August 2026 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
EPEmir Becirovic, MD, PhD, Asst. prof.
Emir Becirovic, MD, PhD, Asst. prof.
MBMinela Becirovic Becirovic
Minela Becirovic Becirovic
ABAmir Bećirović
Amir Bećirović
ATAmir Tursunovic
Amir Tursunovic
ABAjla Bajrić
Ajla Bajrić
LFLamija Ferhatbegovic
Lamija Ferhatbegovic
Background/Objectives: Early risk stratification remains challenging in patients with non-ST-segment elevation myocardial infarction (NSTEMI). The present study evaluated the prognostic value of 24 h high-sensitivity cardiac troponin I (hs-Troponin I) and assessed whether combining biomarkers and echocardiographic parameters improves short-term risk prediction. Methods: This prospective observational cohort study included 170 consecutive adult patients with confirmed NSTEMI who were admitted to a Medical Intensive Care Unit and prospectively enrolled between February 2022 and January 2023. Clinical, routine biochemical, inflammatory, hematological, lipid, and echocardiographic data were collected during index hospitalization. High-sensitivity cardiac troponin I was measured at admission and again 24 h after hospitalization, with the 24 h value used as the principal marker of myocardial injury in the prediction analyses. The primary endpoint was major adverse cardiovascular events (MACEs), defined as cardiovascular death, recurrent myocardial infarction, ischemic stroke, urgent coronary revascularization, or hospitalization for worsening heart failure, within 3 months. Multivariable logistic regression, Cox regression, sequential prediction modeling, and internal bootstrap validation were performed. Results: MACEs occurred in 88 patients (51.8%). Twenty-four-hour hs-Troponin I, but not admission hs-Troponin I, was independently associated with MACEs (OR 1.57, 95% CI 1.09–2.26; p = 0.015) and a shorter time to the first MACE event (HR 1.38, 95% CI 1.07–1.78; p = 0.012). Lower left ventricular ejection fraction (LVEF) was also independently associated with adverse outcomes. The addition of 24 h hs-Troponin I, LVEF, and C-reactive protein improved discrimination from an AUC of 0.665 to 0.759 (optimism-corrected AUC, 0.717), with corresponding improvements in reclassification. A simplified multimarker score was independently associated with event-free survival (HR 2.36, 95% CI 1.53–3.64; p < 0.001). Conclusions: In patients admitted to a medical intensive care unit with NSTEMI, the integration of 24 h hs-Troponin I, LVEF, and C-reactive protein improved short-term risk prediction beyond that of clinical variables alone. A practical multimarker model based on routinely available parameters identified patients at increased risk of adverse cardiovascular outcomes during early follow-up.

27 February 2026 in Medicinski Glasnik
Verified
Journal Article
Open access
ATAnesa Terzić
Anesa Terzić
EMElma Mujaković
Elma Mujaković
EPEmir Becirovic, MD, PhD, Asst. prof.
Emir Becirovic, MD, PhD, Asst. prof.
MBMinela Bećirović
Minela Bećirović
AĆAlmira Ćosićkić
Almira Ćosićkić
Aim Vaccine hesitancy challenges global public health, with parental attitudes significantly impacting childhood immunization. This study examined parental perceptions of vaccine safety, effectiveness, and decision-making factors in Bosnia and Herzegovina. Methods A cross-sectional survey was conducted in March 2025 with 233 parents at a Primary Healthcare Center in Gračanica. A structured questionnaire based on the Parent Attitude about Childhood Vaccines (PACV) assessed sociodemographic data, vaccination experiences, information sources, and attitudes toward vaccines using a Likert scale. Results Among 233 participants, 195 (83.7%) fully vaccinated their children, 30 (12.9%) practiced selective vaccination, and eight (3.4%) refused all vaccines. Vaccine hesitancy was significantly associated with lower education, (26.3% vs. 5.1%; p<0.001), rural residence (76.3% vs. 48.2%; p=0.002), and having three or more children (34.2% vs. 12.3%; p=0.01). Trust in healthcare professionals strongly influenced behavior, with 178 (91.3%) of parents who fully trusted doctors adhering to the immunization schedule. Concerns about autism were reported by 14 (36.8%) of hesitant parents and were significantly associated with delayed or refused vaccination (p<0.001). Conclusion Although overall confidence was high, vaccine hesitancy persisted due to perceived risks. Strengthening healthcare communication and addressing misinformation, particularly autism concerns, may help improve vaccine uptake. Keywords: health knowledge, immunization program, public health, vaccination coverage

17 June 2026 in Medicinski Glasnik
Verified
Journal Article
Open access
PDF file
MBMinela Becirovic Becirovic
Minela Becirovic Becirovic
EPEmir Becirovic, MD, PhD, Asst. prof.
Emir Becirovic, MD, PhD, Asst. prof.
JHJusuf Hodžić
Jusuf Hodžić
ABAmir Bećirović
Amir Bećirović
EMElma Mujaković
Elma Mujaković
RGRadojka Golijan
Radojka Golijan

17 June 2026 in Medicinski Glasnik
Verified
Journal Article
Open access
PDF file
MBMinela Becirovic Becirovic
Minela Becirovic Becirovic
EPEmir Becirovic, MD, PhD, Asst. prof.
Emir Becirovic, MD, PhD, Asst. prof.
ABAmir Bećirović
Amir Bećirović
SHSemir Hadžić
Semir Hadžić
AAAdmir Abdić
Admir Abdić
NLNadina Ljuca
Nadina Ljuca
Aim: To evaluate the prognostic value of the CHA₂DS₂-VASc score in relation to major adverse cardiovascular events (MACE) and cardiovascular mortality in patients with non-ST elevation myocardial infarction (NSTEMI), and to assess its association with clinical and echocardiographic characteristics. Methods: This prospective, observational, cohort study included 311 NSTEMI patients admitted to the Internal Medicine Clinic at the University Clinical Centre Tuzla between January 2023 and April 2024. The patients were stratified into intermediate-risk (score < 4) and high-risk (score ≥ 4) groups based on the CHA₂DS₂-VASc score at admission. Demographic, clinical, and echocardiographic data were collected, including electrocardiography (ECG) and transthoracic echocardiography. All patients were followed for 3 months (90 days) to assess the occurrence of MACE and cardiovascular mortality. Results: The patients in the high-risk group were older and had significantly lower left ventricular ejection fractions and larger left atrial diameters compared with the intermediate-risk group. During the 3-month follow-up, MACE occurred in 11.9% of high-risk and 3.9% of intermediate-risk patients; cardiovascular mortality was observed exclusively in the high-risk group (2.5%). A higher CHA₂DS₂-VASc score was significantly associated with cardiovascular mortality (p = 0.003), but not with overall MACE (p = 0.393). Moderate predictive accuracy for mortality (AUC = 0.64) and shorter event-free survival in the high-risk group (log-rank p = 0.005) were observed. Conclusion: The CHA₂DS₂-VASc score showed potential as a simple and accessible tool for early identification of NSTEMI patients at risk of cardiovascular death. Its significant association with mortality supports its role as a supplementary risk stratification tool, although these findings require validation in larger, multicentre studies.